Evonik Industries (FRA:EVK) received a €23.00 ($26.74) price target from investment analysts at UBS Group in a note issued to investors on Monday, Borsen Zeitung reports. The brokerage currently has a “sell” rating on the stock. UBS Group’s price objective suggests a potential downside of 10.82% from the stock’s previous close.
A number of other research firms have also commented on EVK. JPMorgan Chase & Co. restated a “neutral” rating on shares of Evonik Industries in a research report on Tuesday, January 22nd. Nord/LB set a €29.00 ($33.72) price objective on shares of Evonik Industries and gave the stock a “neutral” rating in a report on Thursday, January 24th. Berenberg Bank set a €30.00 ($34.88) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a report on Thursday, March 7th. Commerzbank set a €35.00 ($40.70) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a report on Monday, March 4th. Finally, Sanford C. Bernstein set a €31.00 ($36.05) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a report on Tuesday, May 7th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have given a buy rating to the stock. Evonik Industries presently has a consensus rating of “Hold” and a consensus price target of €30.93 ($35.96).
Evonik Industries stock opened at €25.79 ($29.99) on Monday. Evonik Industries has a 1-year low of €26.78 ($31.14) and a 1-year high of €32.97 ($38.34).
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Article: What is an SEC Filing?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.